Sign in
LIPO Stock Price, Chart, Stats & News
Lipella Pharmaceuticals Inc.
Save
Lipella Pharmaceuticals Inc. (LIPO) does not currently pay a dividend.
2,310
Market cap
–
Current P/E
–
Forward P/E
LIPO chart
About
Health care
Sector
Biotechnology
Industry
Lipella Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the creation of novel therapies. The company achieves this by repurposing and optimizing the active ingredients found in established generic drugs, tailoring these reformulations for diverse medical applications. Its lead candidate, LP-10, a tacrolimus formulation, is presently in Phase IIa clinical studies, targeting radiation-induced hemorrhagic cystitis.
Similar securities
Based on sector and market capitalization
Report issue